Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Chinese Patent Office
Express Scripts
Baxter
Queensland Health
Medtronic
Covington
Boehringer Ingelheim

Generated: October 15, 2018

DrugPatentWatch Database Preview

Actavis Totowa Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS TOTOWA, and what generic and branded alternatives to ACTAVIS TOTOWA drugs are available?

ACTAVIS TOTOWA has twenty-two approved drugs.



Summary for Actavis Totowa
US Patents:0
Tradenames:17
Ingredients:17
NDAs:22
Patent Litigation for Actavis Totowa: See patent lawsuits for Actavis Totowa

Drugs and US Patents for Actavis Totowa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071766-001 Oct 5, 1987 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Totowa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065445-003 Sep 18, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Totowa TOPIRAMATE topiramate TABLET;ORAL 078637-004 Feb 27, 2013 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Totowa CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 078732-001 Feb 6, 2012 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Totowa REPAGLINIDE repaglinide TABLET;ORAL 090008-003 Jan 22, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Totowa CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 078732-003 Feb 6, 2012 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Totowa OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 078803-001 Aug 8, 2012 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
QuintilesIMS
AstraZeneca
Covington
UBS
Harvard Business School
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.